1·Objective To observe the effect of Irbesartan on hypertension patients with paroxysmal atrial fibrillation and left atrial size.
目的观察厄贝沙坦对原发性高血压患者阵发性心房纤颤及其左心房大小的影响。
2·The invention discloses an irbesartan hydrochlorothiazide capsule and a preparation method thereof, belonging to the technical field of medicines.
本发明公开了一种厄贝沙坦氢氯噻嗪胶囊及其制备方法，属于医药技术领域。
3·Objective to evaluate the effect of irbesartan combined with atorvastatin on relapse of paroxysmal atrial fibrillation (PAF) in patients with acute myocardial infarction (AMI) complicated by PAF.
目的探讨厄贝沙坦联合阿托伐他汀对合并阵发性心房颤动(PAF)的急性心肌梗死(ami)患者心房颤动复发的防治作用。
4·ObjectiveTo investigate the effect of combination of irbesartan and sotalol in patients with paroxysmal atrial fibrillation.
目的评价厄贝沙坦联合索他洛尔治疗阵发性心房纤颤的效果。
5·Conclusion: Irbesartan combined with conventional treatment of chronic heart failure has further beneficial effect, and has a good safety and tolerability.
结论：常规治疗联合厄贝沙坦治疗慢性心衰，可进一步获得有益的疗效，并且有良好的安全性及耐受性。
1·Conclusion Compared with amlodipine, irbesartan not only has obvious effect on lowering blood pressure, but also has better safety and toleration.
结论与氨氯地平相比，伊贝沙坦不仅在降压上有明显疗效，而且有较好的安全性和耐受性。
2·Objective: To observe the effect of irbesartan on proteinuria in benign arteriolar nephrosclerosis patients.
目的：观察伊贝沙坦对良性小动脉性肾硬化蛋白尿的效应。
3·Objective it is to discuss the protection of Irbesartan on endothelial function of blood vessel in patients with essential hypertension (EH).
目的探讨伊贝沙坦对原发性高血压(EH)患者血管内皮功能的保护作用。
4·Objective to evaluate the risk factors of Irbesartan in treatment of essential hypertension and to explore individualized antihypertensive treatment.
目的为了探讨原发性高血压患者伊贝沙坦降压疗效的影响因素。